Moreover, CCL2–CCR2 signaling enhances metalloproteinase MMP2 and MMP9 production in human chondrosarcoma and hepatoma cells, which elicits detrimental effects on cancer cell invasion and motility [61,62]. This evidence concerns the gene MMP2 and cancer.